[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

ALPN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 42.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $288,588.09

Alpine Immune Sciences Insider Trading History Chart

Alpine Immune Sciences Share Price & Price History

^$15.07

▲ +0.15 (1.01%)

As of 11/28/2023 01:00 AM ET

Days: 30 | 90 | 365

An Unusual Way to Invest in Gold

From Edge On The Street | Ad

Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.

See why this overlooked gold play

Alpine Immune Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/6/2023	James Paul Rickey	insider	Sell	18,003	$16.03	$288,588.09
2/11/2022	Life Sciences Viii L Frazier	Major Shareholder	Buy	112,665	$7.10	$799,921.50
9/21/2021	Robert E. Conway	Director	Buy	10,000	$9.80	$98,000.00
9/17/2021	Decheng Capital China Life Sci	Major Shareholder	Buy	1,542,553	$9.40	$14,499,998.20
9/17/2021	Mitchell H. Gold	CEO	Sell	45,262	$10.01	$453,072.62
9/17/2021	Orbimed Advisors Llc	Director	Buy	1,010,637	$9.40	$9,499,987.80
9/15/2021	Mitchell H. Gold	CEO	Sell	3,484	$10.00	$34,840.00
6/28/2021	Mitchell H. Gold	CEO	Sell	3,479	$10.00	$34,790.00	168,380
6/25/2021	Mitchell H. Gold	CEO	Sell	9,473	$10.01	$94,824.73	168,380
5/19/2021	Mitchell H. Gold	CEO	Sell	50,965	$15.03	$766,003.95	179,074
5/12/2021	Mitchell H. Gold	CEO	Sell	10,000	$11.68	$116,800.00	240,039
4/13/2021	Mitchell H. Gold	CEO	Sell	10,000	$10.07	$100,700.00	260,039
3/4/2021	Mitchell H. Gold	CEO	Sell	10,000	$13.01	$130,100.00	280,039
12/28/2020	Orbimed Advisors Llc	Director	Sell	600,000	$14.25	$8,550,000.00

An Unusual Way to Invest in Gold

From Edge On The Street | Ad

See why this overlooked gold play

SEC Filings (Institutional Ownership Changes) for Alpine Immune Sciences (NASDAQ:ALPN)

75.17% of Alpine Immune Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Alpine Immune Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/24/2023	Deutsche Bank AG	17,511	$0.20M	0.0%	-86.2%	0.030%
11/21/2023	Walleye Capital LLC	186,273	$2.13M	0.0%	+13.1%	0.321%
11/15/2023	The Manufacturers Life Insurance Company	28,383	$0.33M	0.0%	+110.5%	0.058%
11/15/2023	Legal & General Group Plc	22,715	$0.26M	0.0%	+550.5%	0.046%
11/14/2023	Schonfeld Strategic Advisors LLC	90,937	$1.04M	0.0%	+604.9%	0.185%
11/14/2023	Avidity Partners Management LP	657,280	$7.53M	0.3%	-37.9%	1.336%
11/14/2023	Lynx1 Capital Management LP	2,404,614	$27.53M	18.2%	-10.0%	4.887%
11/14/2023	California State Teachers Retirement System	23,993	$0.28M	0.0%	+127.2%	0.049%
11/14/2023	Qube Research & Technologies Ltd	10,070	$0.12M	0.0%	N/A	0.020%
11/14/2023	Trexquant Investment LP	28,578	$0.33M	0.0%	-33.2%	0.058%
11/14/2023	Nan Fung Group Holdings Ltd	182,280	$2.09M	1.7%	N/A	0.370%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	45,475	$0.52M	0.0%	-2.4%	0.092%
11/13/2023	Algert Global LLC	20,010	$0.23M	0.0%	N/A	0.041%
11/13/2023	Northern Trust Corp	270,424	$3.10M	0.0%	+5.0%	0.550%
11/13/2023	Invesco Ltd.	217,136	$2.49M	0.0%	N/A	0.441%
11/13/2023	FMR LLC	464,812	$5.32M	0.0%	-31.2%	0.945%
11/9/2023	Rhumbline Advisers	41,403	$0.47M	0.0%	+5.0%	0.084%
11/9/2023	Deutsche Bank AG	17,511	$0.20M	0.0%	-86.2%	0.036%
11/9/2023	UBS Group AG	19,047	$0.22M	0.0%	-58.5%	0.039%
11/8/2023	Charles Schwab Investment Management Inc.	234,256	$2.68M	0.0%	+171.5%	0.476%
11/8/2023	Swiss National Bank	42,200	$0.48M	0.0%	N/A	0.086%
11/7/2023	New York State Common Retirement Fund	9,634	$0.11M	0.0%	+75.8%	0.020%
11/7/2023	Barclays PLC	9,126	$0.10M	0.0%	+44.3%	0.019%
10/24/2023	Bank of New York Mellon Corp	92,723	$1.06M	0.0%	+1.3%	0.188%
10/13/2023	SG Americas Securities LLC	9,927	$0.11M	0.0%	N/A	0.020%
9/21/2023	Barclays PLC	6,325	$65K	0.0%	-47.6%	0.013%
8/21/2023	Affinity Asset Advisors LLC	118,891	$1.22M	0.4%	-52.0%	0.242%
8/21/2023	California State Teachers Retirement System	10,559	$0.11M	0.0%	+20.0%	0.021%
8/16/2023	Nuveen Asset Management LLC	93,677	$0.96M	0.0%	+195.2%	0.195%
8/15/2023	Alliancebernstein L.P.	15,820	$0.16M	0.0%	N/A	0.033%
8/15/2023	Wells Fargo & Company MN	12,681	$0.13M	0.0%	+188.7%	0.026%
8/15/2023	Walleye Capital LLC	164,673	$1.69M	0.0%	+382.7%	0.343%
8/15/2023	Woodline Partners LP	237,564	$2.44M	0.0%	N/A	0.495%
8/15/2023	Goldman Sachs Group Inc.	55,775	$0.57M	0.0%	+80.8%	0.116%
8/15/2023	RA Capital Management L.P.	4,691,178	$48.23M	0.9%	+0.1%	9.779%
8/15/2023	Royal Bank of Canada	2,642	$27K	0.0%	+99.1%	0.006%
8/14/2023	Schonfeld Strategic Advisors LLC	12,900	$0.13M	0.0%	N/A	0.027%
8/14/2023	Great Point Partners LLC	3,363,688	$34.58M	6.8%	-10.1%	7.012%
8/14/2023	State Street Corp	572,842	$5.89M	0.0%	+65.2%	1.194%
8/14/2023	Nuveen Asset Management LLC	93,677	$0.96M	0.0%	+195.2%	0.195%
8/11/2023	Renaissance Technologies LLC	319,294	$3.28M	0.0%	-3.3%	0.666%
8/11/2023	Westwood Holdings Group Inc.	43,799	$0.45M	0.0%	N/A	0.091%
8/11/2023	BlackRock Inc.	2,281,692	$23.46M	0.0%	+46.9%	4.756%
8/11/2023	Panagora Asset Management Inc.	12,394	$0.13M	0.0%	N/A	0.026%
8/11/2023	The Manufacturers Life Insurance Company	13,483	$0.14M	0.0%	N/A	0.028%
8/11/2023	Trexquant Investment LP	42,773	$0.44M	0.0%	N/A	0.089%
8/11/2023	Geode Capital Management LLC	617,974	$6.35M	0.0%	+11.1%	1.288%
8/11/2023	JPMorgan Chase & Co.	26,349	$0.27M	0.0%	-45.3%	0.055%
8/11/2023	Northern Trust Corp	257,524	$2.65M	0.0%	+32.8%	0.537%
8/11/2023	ExodusPoint Capital Management LP	62,839	$0.65M	0.0%	N/A	0.131%
8/10/2023	MetLife Investment Management LLC	16,818	$0.17M	0.0%	+39.8%	0.035%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	17,081	$0.18M	0.0%	N/A	0.036%
8/10/2023	Charles Schwab Investment Management Inc.	86,280	$0.89M	0.0%	+28.3%	0.180%
8/10/2023	Citigroup Inc.	10,276	$0.11M	0.0%	+1,864.8%	0.021%
8/9/2023	Dimensional Fund Advisors LP	141,499	$1.46M	0.0%	+1.3%	0.295%
8/9/2023	BNP Paribas Arbitrage SNC	8,489	$87K	0.0%	-58.6%	0.018%
8/4/2023	American International Group Inc.	15,279	$0.16M	0.0%	+33.8%	0.032%
8/3/2023	Barclays PLC	6,325	$65K	0.0%	-47.6%	0.013%
8/3/2023	Bank of New York Mellon Corp	91,507	$0.94M	0.0%	+27.4%	0.191%
5/18/2023	JPMorgan Chase & Co.	48,149	$0.37M	0.0%	+238.4%	0.100%
5/16/2023	Susquehanna International Group LLP	10,634	$82K	0.0%	-52.0%	0.022%
5/16/2023	State Street Corp	346,671	$2.68M	0.0%	+14.3%	0.723%
5/16/2023	Geode Capital Management LLC	556,207	$4.29M	0.0%	+14.5%	1.160%
5/16/2023	Great Point Partners LLC	3,740,761	$28.88M	5.7%	+2.8%	7.799%
5/16/2023	BVF Inc. IL	858,339	$6.63M	0.2%	-24.4%	1.789%
5/15/2023	Two Sigma Advisers LP	40,975	$0.32M	0.0%	-37.1%	0.085%
5/15/2023	Deutsche Bank AG	14,751	$0.11M	0.0%	+80.9%	0.031%
5/15/2023	Ghost Tree Capital LLC	200,000	$1.54M	0.5%	N/A	0.417%
5/12/2023	Renaissance Technologies LLC	330,294	$2.55M	0.0%	-0.8%	0.689%
5/12/2023	BlackRock Inc.	1,552,920	$11.99M	0.0%	+8.1%	3.237%
5/12/2023	BNP Paribas Arbitrage SNC	20,518	$0.16M	0.0%	+32.3%	0.043%
5/12/2023	UBS Group AG	7,993	$62K	0.0%	+251.2%	0.017%
5/12/2023	Dimensional Fund Advisors LP	139,672	$1.08M	0.0%	+41.4%	0.291%
5/12/2023	Charles Schwab Investment Management Inc.	67,266	$0.52M	0.0%	+4.3%	0.140%
5/11/2023	Rhumbline Advisers	32,848	$0.25M	0.0%	+25.2%	0.068%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	54,237	$0.42M	0.0%	-7.0%	0.113%
5/9/2023	Bank of New York Mellon Corp	71,806	$0.55M	0.0%	-14.1%	0.150%
5/4/2023	Barclays PLC	12,079	$93K	0.0%	+98.7%	0.025%
4/28/2023	SG Americas Securities LLC	11,927	$92K	0.0%	N/A	0.025%
3/23/2023	MetLife Investment Management LLC	12,028	$88K	0.0%	N/A	0.040%
2/15/2023	MetLife Investment Management LLC	12,028	$88K	0.0%	N/A	0.040%
2/15/2023	Morgan Stanley	17,561	$0.13M	0.0%	+51.9%	0.058%
2/15/2023	Avidity Partners Management LP	1,028,200	$7.56M	0.2%	+3.0%	3.382%
2/14/2023	RA Capital Management L.P.	4,397,368	$32.32M	0.7%	+0.9%	14.465%
2/14/2023	Price T Rowe Associates Inc. MD	19,401	$0.14M	0.0%	+53.8%	0.064%
2/14/2023	Susquehanna International Group LLP	22,162	$0.16M	0.0%	N/A	0.073%
2/14/2023	Pura Vida Investments LLC	30,924	$0.23M	0.0%	N/A	0.102%
2/13/2023	Charles Schwab Investment Management Inc.	64,496	$0.47M	0.0%	+62.0%	0.212%
2/13/2023	Barclays PLC	6,080	$45K	0.0%	+818.4%	0.020%
2/13/2023	Renaissance Technologies LLC	332,894	$2.45M	0.0%	-7.2%	1.095%
2/13/2023	Geode Capital Management LLC	485,750	$3.57M	0.0%	+93.1%	1.598%
2/13/2023	JPMorgan Chase & Co.	14,230	$0.11M	0.0%	+34.6%	0.047%
2/10/2023	Bank of America Corp DE	23,666	$0.17M	0.0%	+259.1%	0.078%
2/10/2023	American International Group Inc.	10,710	$79K	0.0%	+44.4%	0.035%
2/10/2023	Cheyne Capital Management UK LLP	181,886	$1.34M	2.3%	N/A	0.598%
2/9/2023	Dimensional Fund Advisors LP	98,807	$0.73M	0.0%	+92.3%	0.325%
1/23/2023	Allspring Global Investments Holdings LLC	4,453	$33K	0.0%	-96.6%	0.015%
12/8/2022	Bank of New York Mellon Corp	64,480	$0.46M	0.0%	+10.1%	0.212%
11/16/2022	BNP Paribas Arbitrage SNC	6,572	$47K	0.0%	+88.7%	0.022%
11/15/2022	State Street Corp	278,982	$2.01M	0.0%	+4.1%	0.918%

Data available starting January 2016

Alpine Immune Sciences, Inc. operates as a clinical-stage immunotherapy company. It focuses on creating various immunotherapies through protein engineering technologies for autoimmune and inflammatory diseases. The company has strategic collaborations with biopharmaceutical companies and has a pipeline of clinical and preclinical candidates in development. Its pipeline includes Povetacicept, a dual B cell cytokine antagonist for multiple autoimmune and inflammatory diseases; and Acazicolcept, a dual inhibitor of the CD28 and ICOS T cell costimulatory pathways for treatment of severe inflammatory diseases. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

Today's Range

Now: $15.07

$14.58

$15.27

50 Day Range

MA: $11.70

$8.54

$16.07

52 Week Range

Now: $15.07

$5.81

$16.26

Volume

186,291 shs

Average Volume

928,398 shs

Market Capitalization

$875.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Alpine Immune Sciences?: Alpine Immune Sciences' top insider shareholders include:
James Paul Rickey (Insider)
Life Sciences Viii L Frazier (Major Shareholder)
Learn More about top insider investors at Alpine Immune Sciences.
Who are the major institutional investors of Alpine Immune Sciences?: Alpine Immune Sciences' top institutional shareholders include:
Lynx1 Capital Management LP — 4.89%
Avidity Partners Management LP — 1.34%
FMR LLC — 0.94%
Northern Trust Corp — 0.55%
Charles Schwab Investment Management Inc. — 0.48%
Invesco Ltd. — 0.44%
Learn More about top institutional investors of Alpine Immune Sciences stock.
Which institutional investors are selling Alpine Immune Sciences stock?: In the previous quarter, ALPN stock was sold by these institutional investors:
Avidity Partners Management LP
Lynx1 Capital Management LP
FMR LLC
Deutsche Bank AG
Deutsche Bank AG
UBS Group AG
Trexquant Investment LP
Connor Clark & Lunn Investment Management Ltd.
Which institutional investors are buying Alpine Immune Sciences stock?: Within the previous quarter, ALPN stock was purchased by institutional investors including:
Invesco Ltd.
Nan Fung Group Holdings Ltd
Charles Schwab Investment Management Inc.
Schonfeld Strategic Advisors LLC
Swiss National Bank
Walleye Capital LLC
Algert Global LLC
Legal & General Group Plc